Acute liver failure associated with influenza A virus infection: an autopsy case report.
暂无分享,去创建一个
T. Ishiwata | S. Murayama | H. Hasegawa | N. Nakajima | T. Arai | M. Itabashi | A. Hamamatsu | Y. Matsuda | T. Takei | T. Matsubara | K. Nonaka | Noriko Yamanaka | Yasuhiro Sakashita | Shoichiro Takakuma | Mototsune Kakizaki
[1] Lanjuan Li,et al. Prevalence and characteristics of hypoxic hepatitis in the largest single-centre cohort of avian influenza A(H7N9) virus-infected patients with severe liver impairment in the intensive care unit , 2016, Emerging Microbes & Infections.
[2] J. Henrion. Hypoxic hepatitis , 2012, Liver international : official journal of the International Association for the Study of the Liver.
[3] M. Ison,et al. Efficacy and Safety of Oral Oseltamivir for Influenza Prophylaxis in Transplant Recipients , 2012, Antiviral therapy.
[4] T. Takara,et al. Hypoxic hepatopathy: pathophysiology and prognosis. , 2007, Internal medicine.
[5] J. O'connor,et al. Acute hepatitis and liver failure associated with influenza A infection in children. , 2006, Journal of pediatric gastroenterology and nutrition.
[6] A. Delannoy,et al. Hypoxic Hepatitis: Clinical and Hemodynamic Study in 142 Consecutive Cases , 2003, Medicine.
[7] R. Sung,et al. Pathology of fatal human infection associated with avian influenza A H5N1 virus , 2001, Journal of medical virology.
[8] A. Monto,et al. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. , 2000, The New England journal of medicine.
[9] Laurent Kaiser,et al. Influenza virus neuraminidase inhibitors , 2000, The Lancet.
[10] ohnson,et al. USE OF THE SELECTIVE ORAL NEURAMINIDASE INHIBITOR OSELTAMIVIR TO PREVENT INFLUENZA , 2000 .